Spiris-17y – Against Lymphatic Cancer (90 Capsules)

600.00

Spiris-17y is effective in killing various types of cancer cells, but primarily targets Lymphatic cancer cells, including:

  • Non-Hodgkin lymphomas: Diffuse large B-cell lymphoma, Anaplastic large-cell lymphoma, Burkitt lymphoma, Lymphoblastic lymphoma, Mantle cell lymphoma, Peripheral T-cell lymphoma, Waldenstrom macroglobulinemia;
  • Follicular lymphoma, Cutaneous T-cell lymphoma, Lymphoplasmacytic lymphoma, Marginal zone B-cell lymphoma, MALT lymphoma, Small-cell lymphocytic lymphoma;
  • Hodgkin’s lymphoma.
Category:

Description

Spiris-17y – Against Lymphatic Cancer


Spiris-17y is one of the components of the advanced anticancer cure by multiplying the bioactive secondary metabolites of desert plants, targeting different forms and types of Lymphatic cancer.

The mechanism by which these compounds are able to destroy cancer cells, among others, is:

  • through powerful antioxidant, anticarcinogenic, cytotoxicity, antiproliferative, anti-inflammatory, antimicrobial, antiviral, antifungal, hepatoprotective, biosorbent, neuroprotective, antidiabetic, anti-infertility, anti-fatigue, anti-aging activity, has a modifying effect on the intestinal microbiota, has protective activity against oxidative stress, anti-osteoporotic, anti-ulcer, hypoglycemic, induces cell cycle arrest and apoptosis, damage to cancer angiogenesis and suppression of metastases;
  • through repair of oxidative damage, carcinogenic inactivation, inhibition of proliferation, promotion of differentiation, induction of cell cycle arrest and apoptosis, impairment of cancer angiogenesis and suppression of metastasis;
  • through immune remodeling and mitochondrial DNA management.

Unlike the chemical anti-cancer treatments currently used by conventional medicine, Spiris-17y and its companions are able to destroy even cancer cells that are resistant to chemotherapy.
Spiris-17y and its companions are not affected by P-glycoprotein, the enzyme responsible for the resistance of cancer cells to anti-cancer drugs.
Spiris-17y is effective in killing various types of cancer cells, but primarily targets Lymphatic cancer cells, including:

  • Non-Hodgkin lymphomas: Diffuse large B-cell lymphoma, Anaplastic large-cell lymphoma, Burkitt lymphoma, Lymphoblastic lymphoma, Mantle cell lymphoma, Peripheral T-cell lymphoma, Waldenstrom macroglobulinemia;
  • Follicular lymphoma, Cutaneous T-cell lymphoma, Lymphoplasmacytic lymphoma, Marginal zone B-cell lymphoma, MALT lymphoma, Small-cell lymphocytic lymphoma;
  • Hodgkin’s lymphoma.

Spiris-17y also has many positive effects on the patient’s body and health, including:

– Fights toxins in the blood and cleanses the body of toxic substances.

– Stimulates the function of the liver and spleen.

– Helps digestion and removes flatulence.

– Helps to get rid of bronchial pulmonary secretions.

– Helps to cure allergic diseases.

– Soothes mild and moderate bone pain.


Note!

  • It is recommended to take 1 capsule 3 times a day.
  • It has no side effects and is completely safe for everyone.
  • It can be taken by everyone without exception; pregnant or lactating women, and children.
  • It reduces the damage and side effects of chemotherapy and radiotherapy, and can be taken alongside them without any intervention or complication.
  • It is recommended to be taken together with the other components of the complete cure depending on the condition of each patient.
  • Store in a cool place, away from heat and direct sunlight.

Ingredients

  • Spiris-17y is a unique advanced formula from desert plants, which comes with the multiplication of bioactive secondary metabolites of the most selected desert plants, harmonized with WAH’s Special Formula.
  • Our capsules are vegetarian (vegetable), consisting of cellulose, an important structural component of plants.
  • DOES NOT CONTAIN: ingredients derived from genetically modified organisms (GMOs), artificial colors, preservatives or Gluten.